Clinical Trial: Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research

U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07623668) titled 'Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research' on May 28.

Brief Summary: The goal of this clinical trial is to evaluate the safety and efficacy of privosegtor, a neuroprotective candidate, in patients diagnosed with optic neuritis (ON).

Researchers will compare privosegtor and the standard of care (methylprednisolone) to a placebo and standard of care (methylprednisolone).

Study Start Date: May 28

Study Type: INTERVENTIONAL

Condition: Optic Neuritis

Intervention: DRUG: Privosegtor

Privosegtor (OCS-05) 3 mg/kg/day IV for 5 treatment days

DRUG: Methylprednisolone

Methylprednisolone 1 g/day IV fo...